A pair of new studies has revealed that the hellish skies of exoplanet WASP-121b contain silicon monoxide gas, which has ...

As a chemist at Florida State, he pioneered techniques used in the large-scale production of Taxol, a blockbuster anti-cancer agent.

A team of chemists at the University of Cambridge has developed a powerful new method for adding single carbon atoms to ...

§Present address: Catalysis Research Center, Hokkaido University, N21W10, Kita, Sapporo, Hokkaido 001-0021, Japan. Article Views are the COUNTER-compliant sum of full text article downloads since ...

Shuttle-based therapies are under active development for an array of brain conditions. “It’s now abundantly clear that we can ...

In this repository, we present Wan2.1, a comprehensive and open suite of video foundation models that pushes the boundaries of video generation. Wan2.1 offers these key features: If your work has ...

The company said that the proceeds from this would be used to advance the company’s drug discovery platform, progress CP-383 into phase 1/2 clinical proof-of-concept studies, and expand its drug ...

Human exonuclease 1 (EXO1), a member of the structure-specific nuclease family, plays a critical role in maintaining genome stability by processing DNA double-strand breaks (DSBs), nicks, and ...

In a new study, researchers identified a molecule produced by a particular type of brain cell that reversed the cognitive decline seen in both healthy aging and dementia.

AMP (adenosine monophosphate), FAS (fatty acid synthase), ACC1 (acetyl-CoA carboxylase 1), SCD1 (stearoyl-CoA desaturase 1), CPT1A (carnitine acyltransferase 1A), GPR (G protein-coupled receptor ...

The companies will initially commence four development programmes for potential small molecule therapies directed ... including the GLP-1, GIP and glucagon receptors. “Novo Nordisk has a rich ...

GSK said it is ending the development program for the small-molecule drug Belrestotug. The British pharmaceutical giant said Tuesday that the decision is based on a new interim analyses from phase ...